Comparison of pTau217 and Tau PET between Down syndrome and neurotypical adults at risk for Alzheimer's disease
Individuals with DS have earlier pTau217 and Tau PET progression following PET A+ compared to neurotypical adults. The early and simultaneous onset of these biomarkers in DS highlight the necessity for early AD interventions in this population. This work, combined with the upcoming DSAD clinical trials will help identify optimal treatment windows for these individuals.
Authors
- Matthew Zammit (ORCID: https://orcid.org/0000-0001-8966-8397)
Institutions
- University of Wisconsin–Madison (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_099359
- Primary Topic
- Down syndrome and intellectual disability research
- Type
- article
- Field-Weighted Citation Impact
- 0.00